Satoh T - Search Results

1

Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag.

Satoh T, Saotome M, Suwa K, Ohtani H, Nagata Y, Ono T, Maekawa Y. Satoh T, et al. Case Rep Cardiol. 2019 Mar 26;2019:2756319. doi: 10.1155/2019/2756319. eCollection 2019. Case Rep Cardiol. 2019. PMID: 31049228 Free PMC article.

2

Eicosapentaenoic acid ameliorates palmitate-induced lipotoxicity via the AMP kinase/dynamin-related protein-1 signaling pathway in differentiated H9c2 myocytes.

Sakamoto A, Saotome M, Hasan P, Satoh T, Ohtani H, Urushida T, Katoh H, Satoh H, Hayashi H. Sakamoto A, et al. Among authors: satoh t, satoh h. Exp Cell Res. 2017 Feb 1;351(1):109-120. doi: 10.1016/j.yexcr.2017.01.004. Epub 2017 Jan 11. Exp Cell Res. 2017. PMID: 28088331

3

Intracellular Renin Inhibits Mitochondrial Permeability Transition Pore via Activated Mitochondrial Extracellular Signal-Regulated Kinase (ERK) 1/2 during Ischemia in Diabetic Hearts.

Satoh T, Saotome M, Katoh H, Nonaka D, Hasan P, Hayashi H, Maekawa Y. Satoh T, et al. Int J Mol Sci. 2017 Dec 25;19(1):55. doi: 10.3390/ijms19010055. Int J Mol Sci. 2017. PMID: 29295576 Free PMC article.

4

Glycogen synthase kinase-3β opens mitochondrial permeability transition pore through mitochondrial hexokinase II dissociation.

Tanaka T, Saotome M, Katoh H, Satoh T, Hasan P, Ohtani H, Satoh H, Hayashi H, Maekawa Y. Tanaka T, et al. Among authors: satoh t, satoh h. J Physiol Sci. 2018 Nov;68(6):865-871. doi: 10.1007/s12576-018-0611-y. Epub 2018 Apr 18. J Physiol Sci. 2018. PMID: 29671257 Free PMC article.

5

Safety and feasibility of a novel total percutaneous post-closure technique after bedside Impella decannulation in patients with cardiogenic shock.

Suzuki Y, Mogi S, Mizuno Y, Sato R, Satoh T, Ohtani H, Saotome M, Maekawa Y. Suzuki Y, et al. Among authors: satoh t. J Invasive Cardiol. 2024 Feb;36(2). doi: 10.25270/jic/23.00255. J Invasive Cardiol. 2024. PMID: 38335506 Free article.

6

Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.

Akita K, Kageyama S, Suzuki S, Ohno K, Kamakura M, Nawada R, Takanaka C, Wakabayashi Y, Kanda T, Tawarahara K, Mutoh M, Matsunaga M, Suwa S, Takeuchi Y, Sakamoto H, Saito H, Hayashi K, Wakahara N, Unno K, Ikoma T, Sato R, Iguchi K, Satoh T, Sano M, Suwa K, Naruse Y, Ohtani H, Saotome M, Maekawa Y; Searching for Atrial Fibrillation and Early Recruitment of Heart Failure in HCM (SAFER-HCM) Registry Investigators. Akita K, et al. Among authors: satoh t. Heart. 2024 Apr 8:heartjnl-2023-323856. doi: 10.1136/heartjnl-2023-323856. Online ahead of print. Heart. 2024. PMID: 38589224

7

Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer.

Nishida N, Sakai D, Satoh T. Nishida N, et al. Among authors: satoh t. Int J Clin Oncol. 2024 May 11. doi: 10.1007/s10147-024-02500-8. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38733489 Review.

8

Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.

Li BT, Meric-Bernstam F, Bardia A, Naito Y, Siena S, Aftimos P, Anderson I, Curigliano G, de Miguel M, Kalra M, Oh DY, Park JO, Postel-Vinay S, Rha SY, Satoh T, Spanggaard I, Michelini F, Smith A, Machado KK, Saura C; DESTINY-PanTumor01 study group. Li BT, et al. Among authors: satoh t. Lancet Oncol. 2024 May 3:S1470-2045(24)00140-2. doi: 10.1016/S1470-2045(24)00140-2. Online ahead of print. Lancet Oncol. 2024. PMID: 38710187

9

Quality of care measurement for patients with ovarian cancer in Japan.

Kakuwa T, Watanabe T, Niino M, Kawata A, Satoh T, Matsumura N, Yokoyama Y, Kawana K, Hirashima Y, Kyo S, Yasuda M, Harano K, Machida H, Tokunaga H, Kaneuchi M, Tabata T, Kobayashi Y, Nagase S, Katabuchi H, Mikami M, Yamamoto Y, Rikitake R, Ichinose Y, Higashi T. Kakuwa T, et al. Among authors: satoh t. J Obstet Gynaecol Res. 2024 May 2. doi: 10.1111/jog.15961. Online ahead of print. J Obstet Gynaecol Res. 2024. PMID: 38697202

10

Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction.

Suzuki H, Inoue T, Terui Y, Takeuchi K, Susukita K, Arai M, Sato H, Satoh T, Yamamoto S, Yaoita N, Tatebe S, Hayashi H, Nochioka K, Takahama H, Yasuda S. Suzuki H, et al. Among authors: satoh t. ESC Heart Fail. 2024 Apr 29. doi: 10.1002/ehf2.14802. Online ahead of print. ESC Heart Fail. 2024. PMID: 38685602 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,754 results

Search Page